Published in Radiology on November 02, 2010
National Lung Screening Trial (NLST) Screening (NLST) | NCT00047385
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol (2011) 21.49
Benefits and harms of CT screening for lung cancer: a systematic review. JAMA (2012) 8.71
Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med (2013) 5.92
Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 4.83
Cost-effectiveness of CT screening in the National Lung Screening Trial. N Engl J Med (2014) 4.76
Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med (2013) 4.09
Selection criteria for lung-cancer screening. N Engl J Med (2013) 3.69
Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data--methods and preliminary results. Radiology (2012) 2.98
ESR/ERS white paper on lung cancer screening. Eur Respir J (2015) 2.87
Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol (2011) 2.83
Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med (2013) 2.77
Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med (2013) 2.66
Baseline characteristics of participants in the randomized national lung screening trial. J Natl Cancer Inst (2010) 2.50
Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation. J Natl Cancer Inst (2011) 2.31
Decision making in patients with pulmonary nodules. Am J Respir Crit Care Med (2011) 2.05
Primary Care Provider-Delivered Smoking Cessation Interventions and Smoking Cessation Among Participants in the National Lung Screening Trial. JAMA Intern Med (2015) 1.92
Model-based iterative reconstruction technique for radiation dose reduction in chest CT: comparison with the adaptive statistical iterative reconstruction technique. Eur Radiol (2012) 1.89
Low-dose CT of the lung: potential value of iterative reconstructions. Eur Radiol (2012) 1.85
A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Mol Med (2011) 1.83
Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial. Cancer (2014) 1.80
The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology. Cancer (2013) 1.76
Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers. BMC Cancer (2011) 1.74
Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts. PLoS Med (2014) 1.73
Plasma microRNAs as novel biomarkers for early detection of lung cancer. Int J Clin Exp Pathol (2011) 1.73
Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate. Radiology (2013) 1.72
Noninvasive Computed Tomography-based Risk Stratification of Lung Adenocarcinomas in the National Lung Screening Trial. Am J Respir Crit Care Med (2015) 1.70
Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination. J Natl Cancer Inst (2014) 1.64
UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer. Thorax (2011) 1.62
Quantitative CT assessment of emphysema and airways in relation to lung cancer risk. Radiology (2011) 1.62
Computed tomographic characteristics of interval and post screen carcinomas in lung cancer screening. Eur Radiol (2014) 1.59
National Lung Screening Trial findings by age: Medicare-eligible versus under-65 population. Ann Intern Med (2014) 1.56
The state of molecular biomarkers for the early detection of lung cancer. Cancer Prev Res (Phila) (2012) 1.49
A cost-utility analysis of lung cancer screening and the additional benefits of incorporating smoking cessation interventions. PLoS One (2013) 1.46
Serum microRNA biomarkers for detection of non-small cell lung cancer. PLoS One (2012) 1.43
Relationship of Coronary Calcium on Standard Chest CT Scans With Mortality. JACC Cardiovasc Imaging (2016) 1.43
"Sentinel" circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease. PLoS One (2014) 1.34
Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial. Lancet Oncol (2016) 1.30
A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancer. Oncogene (2014) 1.29
Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease. Am J Surg Pathol (2014) 1.29
Previous lung diseases and lung cancer risk: a pooled analysis from the International Lung Cancer Consortium. Am J Epidemiol (2012) 1.27
Tumor Spread through Air Spaces is an Important Pattern of Invasion and Impacts the Frequency and Location of Recurrences after Limited Resection for Small Stage I Lung Adenocarcinomas. J Thorac Oncol (2015) 1.24
Lung cancer in 2010: One size does not fit all. Nat Rev Clin Oncol (2011) 1.20
A computational pipeline for quantification of pulmonary infections in small animal models using serial PET-CT imaging. EJNMMI Res (2013) 1.17
Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment. Ann Intern Med (2015) 1.17
Impact of lung cancer screening results on smoking cessation. J Natl Cancer Inst (2014) 1.15
The National Lung Screening Trial's Endpoint Verification Process: determining the cause of death. Contemp Clin Trials (2011) 1.14
Very low-dose (0.15 mGy) chest CT protocols using the COPDGene 2 test object and a third-generation dual-source CT scanner with corresponding third-generation iterative reconstruction software. Invest Radiol (2015) 1.12
In vivo detection of acinar microstructural changes in early emphysema with (3)He lung morphometry. Radiology (2011) 1.11
Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy. Mol Cancer (2011) 1.10
Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial. J Clin Oncol (2013) 1.08
Systems for lung volume standardization during static and dynamic MDCT-based quantitative assessment of pulmonary structure and function. Acad Radiol (2012) 1.04
Early detection of lung cancer: Low-dose computed tomography screening in China. Thorac Cancer (2015) 1.04
Association of Coronary Artery Calcification and Mortality in the National Lung Screening Trial: A Comparison of Three Scoring Methods. Radiology (2015) 1.03
Multiphoton microscopy and microspectroscopy for diagnostics of inflammatory and neoplastic lung. J Biomed Opt (2012) 1.03
Combining automatic tube current modulation with adaptive statistical iterative reconstruction for low-dose chest CT screening. PLoS One (2014) 1.02
European and North American lung cancer screening experience and implications for pulmonary nodule management. Eur Radiol (2011) 0.96
Predictors of adverse smoking outcomes in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. J Natl Cancer Inst (2012) 0.96
A risk model for lung cancer incidence. Cancer Prev Res (Phila) (2012) 0.95
Recent advances in optical coherence tomography for the diagnoses of lung disorders. Expert Rev Respir Med (2011) 0.95
Equating quantitative emphysema measurements on different CT image reconstructions. Med Phys (2011) 0.94
Lung cancer screening: review and performance comparison under different risk scenarios. Lung (2013) 0.94
Noninvasive detection of lung cancer using exhaled breath. Cancer Med (2013) 0.93
Sensitivity and accuracy of volumetry of pulmonary nodules on low-dose 16- and 64-row multi-detector CT: an anthropomorphic phantom study. Eur Radiol (2012) 0.92
Advances in fine needle aspiration cytology for the diagnosis of pulmonary carcinoma. Patholog Res Int (2011) 0.92
National lung screening trial: variability in nodule detection rates in chest CT studies. Radiology (2013) 0.92
Meta-analysis of the technical performance of an imaging procedure: guidelines and statistical methodology. Stat Methods Med Res (2014) 0.92
Evaluation of solitary pulmonary nodule detected during computed tomography examination. Pol J Radiol (2012) 0.92
Findings in asymptomatic HIV-infected patients undergoing chest computed tomography testing: implications for lung cancer screening. AIDS (2014) 0.92
Serum biomarker profiles as diagnostic tools in lung cancer. Cancer Biomark (2012) 0.91
Lung cancer screening with low-dose computed tomography for primary care providers. Prim Care (2014) 0.90
Lung cancer screening guidelines: common ground and differences. Transl Lung Cancer Res (2014) 0.90
Lung cancer screening with low-dose helical CT: results from the National Lung Screening Trial (NLST). J Med Screen (2011) 0.89
Identifying and collecting pertinent medical records for centralized abstraction in a multi-center randomized clinical trial: the model used by the American College of Radiology arm of the National Lung Screening Trial. Contemp Clin Trials (2012) 0.89
Preoperative consolidation-to-tumor ratio and SUVmax stratify the risk of recurrence in patients undergoing limited resection for lung adenocarcinoma ≤2 cm. Ann Surg Oncol (2013) 0.88
Improved pulmonary nodule classification utilizing quantitative lung parenchyma features. J Med Imaging (Bellingham) (2015) 0.87
Image quality assessment of ultra low-dose chest CT using sinogram-affirmed iterative reconstruction. Eur Radiol (2014) 0.87
Quantitative monitoring of mouse lung tumors by magnetic resonance imaging. Nat Protoc (2012) 0.87
Low-dose CT: technique, reading methods and image interpretation. Cancer Imaging (2013) 0.87
Multi-centre analysis of incidental findings on low-resolution CT attenuation correction images. Br J Radiol (2014) 0.87
Serum unsaturated free Fatty acids: potential biomarkers for early detection and disease progression monitoring of non-small cell lung cancer. J Cancer (2014) 0.86
Emphysema predicts hospitalisation and incident airflow obstruction among older smokers: a prospective cohort study. PLoS One (2014) 0.86
Cancer-prone mice expressing the Ki-rasG12C gene show increased lung carcinogenesis after CT screening exposures. Radiat Res (2011) 0.86
How have we diagnosed early-stage lung cancer without radiographic screening? A contemporary single-center experience. PLoS One (2012) 0.85
The Relations Between False Positive and Negative Screens and Smoking Cessation and Relapse in the National Lung Screening Trial: Implications for Public Health. Nicotine Tob Res (2015) 0.85
Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial. BMJ Open (2015) 0.85
Epigenetic Therapy in Lung Cancer - Role of microRNAs. Front Oncol (2013) 0.84
Trends in Subpopulations at High Risk for Lung Cancer. J Thorac Oncol (2016) 0.83
Systemic Metabolomic Changes in Blood Samples of Lung Cancer Patients Identified by Gas Chromatography Time-of-Flight Mass Spectrometry. Metabolites (2015) 0.83
Tumor Budding Correlates With the Protumor Immune Microenvironment and Is an Independent Prognostic Factor for Recurrence of Stage I Lung Adenocarcinoma. Chest (2015) 0.82
Radiation exposure from imaging tests: is there an increased cancer risk? Expert Rev Cardiovasc Ther (2011) 0.82
Cone Beam Computertomography (CBCT) in Interventional Chest Medicine - High Feasibility for Endobronchial Realtime Navigation. J Cancer (2014) 0.82
Label-acquired magnetorotation as a signal transduction method for protein detection: aptamer-based detection of thrombin. Anal Chem (2011) 0.82
Lung cancer detectability by test, histology, stage, and gender: estimates from the NLST and the PLCO trials. Cancer Epidemiol Biomarkers Prev (2014) 0.82
Implementing the new IASLC/ATS/ERS classification of lung adenocarcinomas: results from international and Chinese cohorts. J Thorac Dis (2014) 0.81
Scatter correction associated with dedicated dual-source CT hardware improves accuracy of lung air measures. Acad Radiol (2013) 0.81
Pulmonary CT and MRI phenotypes that help explain chronic pulmonary obstruction disease pathophysiology and outcomes. J Magn Reson Imaging (2015) 0.81
Longitudinal multistage model for lung cancer incidence, mortality, and CT detected indolent and aggressive cancers. Math Biosci (2012) 0.81
Computer-aided nodule detection and volumetry to reduce variability between radiologists in the interpretation of lung nodules at low-dose screening computed tomography. Invest Radiol (2012) 0.81
Lung cancer screening update. J Carcinog (2013) 0.81
Revisions in the International System for Staging Lung Cancer. Chest (1997) 15.68
Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet (1999) 13.67
Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials (2000) 10.99
Cancer statistics, 2002. CA Cancer J Clin (2002) 10.79
Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst (2008) 8.14
Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med (2001) 7.94
Cigarette smoking among adults--United States, 2007. MMWR Morb Mortal Wkly Rep (2008) 6.82
Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst (2000) 6.77
The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. Control Clin Trials (2000) 6.17
Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med (2002) 5.10
Cigarette smoking among adults--United States, 2002. MMWR Morb Mortal Wkly Rep (2004) 3.41
Concern Early lung cancer action project: initial findings on repeat screenings. Cancer (2001) 2.99
Screening for early lung cancer with low-dose spiral CT: prevalence in 817 asymptomatic smokers. Radiology (2002) 2.92
Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer (2007) 2.85
Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer. Lung Cancer (2005) 2.79
Description and implementation of a quality control program in an imaging-based clinical trial. Acad Radiol (2006) 2.71
Screening for lung cancer. A critique of the Mayo Lung Project. Cancer (1991) 2.47
Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner. Br J Cancer (2001) 2.46
Baseline chest radiograph for lung cancer detection in the randomized Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. J Natl Cancer Inst (2005) 2.24
Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project. J Clin Oncol (2002) 2.18
Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic study. Am Rev Respir Dis (1984) 2.13
Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. Am Rev Respir Dis (1984) 2.11
The changing epidemiology of smoking and lung cancer histology. Environ Health Perspect (1995) 2.07
Lung cancer screening using low-dose spiral CT: results of baseline and 1-year follow-up studies. Chest (2002) 1.98
Chest radiography as the comparison for spiral CT in the National Lung Screening Trial. Acad Radiol (2003) 1.95
Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Memorial Sloan-Kettering study. Am Rev Respir Dis (1984) 1.66
Lung cancer detection. Results of a randomized prospective study in Czechoslovakia. Cancer (1986) 1.54
Screening for disease. AJR Am J Roentgenol (1997) 1.54
Czech Study on Lung Cancer Screening: post-trial follow-up of lung cancer deaths up to year 15 since enrollment. Cancer (2000) 1.44
Impact of computed tomography screening for lung cancer on participants in a randomized controlled trial (NELSON trial). Cancer (2008) 1.39
Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial. Lung Cancer (2007) 1.37
The cumulative risk of lung cancer among current, ex- and never-smokers in European men. Br J Cancer (2004) 1.34
Screening of lung cancer with low dose spiral CT: results of a three year pilot study and design of the randomised controlled trial ''Italung-CT''. Radiol Med (2005) 1.20
Low-dose chest CT: optimizing radiation protection for patients. AJR Am J Roentgenol (2004) 1.17
Lung cancer screening results in the National Cancer Institute New York study. Cancer (2000) 1.16
Primary prevention, smoking, and smoking cessation: implications for future trends in lung cancer prevention. Cancer (2000) 1.04
Biometric design of the Mayo Lung Project for early detection and localization of bronchogenic carcinoma. Cancer (1972) 0.97
Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med (2011) 38.61
Mortality results from a randomized prostate-cancer screening trial. N Engl J Med (2009) 30.05
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet (2007) 22.96
Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med (2005) 14.47
The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med (2007) 12.23
American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin (2007) 12.19
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. J Natl Cancer Inst (2012) 11.91
Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med (2012) 11.48
Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst (2008) 11.27
Overdiagnosis in cancer. J Natl Cancer Inst (2010) 10.31
MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med (2007) 10.28
CT angiography for safe discharge of patients with possible acute coronary syndromes. N Engl J Med (2012) 9.73
A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med (2003) 9.18
Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med (2006) 9.17
Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA (2011) 9.13
A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet (2009) 8.39
Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA (2007) 7.93
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet (2009) 7.30
Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA (2011) 6.45
A randomized study of endobronchial valves for advanced emphysema. N Engl J Med (2010) 6.23
Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med (2013) 5.92
Long-term mortality after screening for colorectal cancer. N Engl J Med (2013) 5.81
Performance of common genetic variants in breast-cancer risk models. N Engl J Med (2010) 5.79
A common standard for conflict of interest disclosure in addiction journals. Addiction (2009) 5.62
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89
Comorbidity and mortality results from a randomized prostate cancer screening trial. J Clin Oncol (2010) 4.84
Systematic reviews of diagnostic test accuracy. Ann Intern Med (2008) 4.84
Cost-effectiveness of CT screening in the National Lung Screening Trial. N Engl J Med (2014) 4.76
Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med (2013) 4.64
Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology (2005) 4.31
New models for large prospective studies: is there a better way? Am J Epidemiol (2012) 3.85
Results of repeat sigmoidoscopy 3 years after a negative examination. JAMA (2003) 3.82
Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81
Cumulative incidence of false-positive test results in lung cancer screening: a randomized trial. Ann Intern Med (2010) 3.79
Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development. Clin Cancer Res (2005) 3.71
Selection criteria for lung-cancer screening. N Engl J Med (2013) 3.69
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
Results from four rounds of ovarian cancer screening in a randomized trial. Obstet Gynecol (2009) 3.59
Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial. BJU Int (2008) 3.51
American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. J Clin Oncol (2009) 3.51
Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae. Clin Infect Dis (2002) 3.48
Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst (2003) 3.44
A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet (2011) 3.37
Postpolypectomy colonoscopy surveillance guidelines: predictive accuracy for advanced adenoma at 4 years. Ann Intern Med (2008) 3.34
Methods for etiologic and early marker investigations in the PLCO trial. Mutat Res (2005) 3.33
Utilization of surveillance colonoscopy in community practice. Gastroenterology (2009) 3.33
Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens. Cancer Prev Res (Phila) (2011) 3.33
Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial. Am J Obstet Gynecol (2005) 3.25
Lung image database consortium: developing a resource for the medical imaging research community. Radiology (2004) 3.19
Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat Genet (2013) 3.17
American Cancer Society lung cancer screening guidelines. CA Cancer J Clin (2013) 3.16
Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities. J Natl Cancer Inst (2010) 3.16
Using relative utility curves to evaluate risk prediction. J R Stat Soc Ser A Stat Soc (2009) 3.04
Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial. J Clin Oncol (2012) 3.03
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer. Cancer Prev Res (Phila) (2011) 3.03
Prostate biopsy following a positive screen in the prostate, lung, colorectal and ovarian cancer screening trial. J Urol (2005) 3.01
Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. Nat Genet (2010) 2.96
Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry. J Clin Oncol (2008) 2.96
A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas. N Engl J Med (2015) 2.88
Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Am J Respir Crit Care Med (2007) 2.86
Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial. J Natl Cancer Inst (2005) 2.82